GMP guidelines for investigational medicinal products (Reg 536/2014)

This regulation sets out the standards for 'good manufacturing practice' (GMP) for medicines being tested in clinical trials. It ensures that investigational drugs are produced consistently and controlled according to quality standards to protect the safety of trial participants.

This affects pharmaceutical companies and manufacturers producing experimental drugs for human use, as well as the inspectors who verify compliance with these quality standards.